2008
DOI: 10.1590/s1516-84842008000200014
|View full text |Cite
|
Sign up to set email alerts
|

Fotoferese extracorpórea

Abstract: Fotoferese extracorpórea é uma modalidade de terapia celular que tem demonstrado eficácia e segurança em pacientes portadores de doenças auto-imunes e mediadas por células T, incluindo esclerodermia, linfoma de células T cutâneo/ Síndrome de

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 27 publications
(31 reference statements)
0
2
0
Order By: Relevance
“…Due to the use of different costing methodologies and cost systems, it is difficult to compare different health services. 16 Thus, it is important to perform economic studies that contribute to the improvement of the health management system in Brazil, providing qualified information for decision-making. The limitations of the ECP in Brazil include the availability of sufficient structure and specialized human resources to perform the procedure and monitor the patient, in addition to the acquisition and maintenance cost of the ECP equipment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to the use of different costing methodologies and cost systems, it is difficult to compare different health services. 16 Thus, it is important to perform economic studies that contribute to the improvement of the health management system in Brazil, providing qualified information for decision-making. The limitations of the ECP in Brazil include the availability of sufficient structure and specialized human resources to perform the procedure and monitor the patient, in addition to the acquisition and maintenance cost of the ECP equipment.…”
Section: Discussionmentioning
confidence: 99%
“…In some cases, this cost can be offset by reducing immunosuppressive therapy, which directly influences outcomes such as hospitalization, quality of life and, sometimes, mortality related to immunosuppressive therapy. 16 However, clinical follow-up studies and economic studies of ECP therapy are still scarce. Thus, this study aims to describe the clinical evolution of patients undergoing ECP as a second-line therapy for cGVHD and to perform an economic analysis of the treatment process.…”
Section: Introductionmentioning
confidence: 99%